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              ABSTRACT 
 
 
 
PREDICTING OUTCOMES OF TRAUMA-EXPOSED WOMEN IN SUBSTANCE USE 
TREATMENT PORGRAMS 
Kaitlin Elizabeth M. Combs 
Western Carolina University (April 2018) 
Director: Dr. L. Alvin Malesky 
Previous research has found various predictors for substance use treatment outcomes, such as relapse 
and re-entry into treatment. However, there is a distinct gap in the research on treatment outcomes for 
women. While gender has not been found to be a predictor in and of itself of treatment outcomes, there 
are distinct differences between predictors for outcomes of men and women. It is also mixed in terms 
of what factors are indicative of negative or positive outcomes and what is considered effective 
treatment. Similarly to gender, too little research has been done to efficiently investigate trauma and its 
role in substance use treatment and it is mixed in terms of whether treating trauma or other mental 
health issues is effective in substance use treatment. Another issue in the current research is its 
variability in what trauma is investigated (i.e. revictimization, polyvictimization, single trauma, etc.). 
The current study was investigated using 3, 078 women in The Comprehensive Addiction and 
Treatment Outcomes (CATOR) system. Thus, the present study seeks to examine the role of trauma 
itself, polyvictimization, and revictimization, on treatment outcomes. 
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CHAPTER ONE: INTRODUCTION 
 
Substance use is common in the general population, particularly legal drugs such as 
alcohol, nicotine, and in some states, marijuana. This has widespread consequences, such as 
criminal activity, traffic death rates, and personal relationship strain. Unlike casual or 
recreational substance use, Substance Use Disorders (SUDs) involve changes in brain 
circuitry and pathological use, which contributes to the development of addiction. This is 
associated with impaired control, social impairment, and risky use (American Psychiatric 
Association, 2013; Chilcoat & Beslau, 1998). In 2014, 8.1% of the population, ages 12 and 
older, met criteria for a Substance Use Disorder (Substance Abuse and Mental Health 
Services Administration, 2014). Thus, there is a significant need for treatment services for 
these individuals. The reality, however, is that the majority of those in need of help with 
substance misuse do not seek treatment. In 2009, only 11.2 % of those with an identified 
Substance Use Disorder received services at a specialized treatment center (National Institute 
on Drug Abuse, 2012). For those who seek treatment, relapse is still a common phenomenon: 
40 to 60% percent of patients do not remain in remission following discharge from a given 
treatment program (NIH, 2012). It is even more difficult for those who have a co-occurring 
mental health disorder, particularly those with Post Traumatic Stress Disorder (PTSD) and 
trauma symptoms, to remain in remission following treatment. This is likely due to negative 
intrapersonal concerns, such as anger and depression and cues for physiological arousal 
(Norman., Tate, Anderson, & Brown, 2007). In 2014, approximately 39% of those with a 
Substance Use Disorder had a co-occurring mental health disorder, (SAMHSA, 2014). 
Women with Substance Use Disorders are especially more likely to have PTSD, to have 
 
previously experienced trauma, or have ongoing trauma than men (Hecksher & Hesse,2009). 
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They face many of the same barriers as others in substance use treatment, albeit more 
pervasively: financial reasons, interpersonal relationships, society’s view on addiction and 
the stigma associated with women who use substances (Hecksher & Hesse, 2009). In 
addition, women are more likely to experience adverse outcomes from substance misuse 
such as rapid development, as well as medical and mental health problem severity (Choo, et 
al., 2014; Piazza, Vrbka, & Yeager, 1989; Randall, et al., 1999). Historically, substance use 
treatment has been male-centric. There has been much debate in the literature as to whether 
current modalities are effective for the female population (Timko, Moos, & Finney, 2016; 
Gerstein & Johnson, 2000; Grella, Scott, Foss, Joshi, & Hser, 2003). Trauma has been 
widely investigated in the literature as it relates to substance use disorder development and 
treatment. There are clear associations between childhood trauma and substance misuse, as 
well as adulthood trauma and substance misuse (Galaif, Stein, Newcomb, & Bernstein, 2001; 
McKay, Lynch, Pettinati, & Shepard, 2003). Many studies have investigated different types 
of trauma, primarily physical and sexual victimization. Those who have experienced 
childhood trauma are likely to experience adulthood trauma (Afifi, et al., 2009). Both 
physical and sexual trauma are associated with negative substance use treatment outcomes, 
such as relapse and poorer treatment retention (Brady, Back, & Coffey, 2004; Jacobsen, 
Southwick, & Kosten, 2001; Simpson, 1979). Emotional trauma has been investigated in the 
substance use literature as well, albeit not as thoroughly (Kuksis, Di Prospero, Hawken, & 
Finch, 2017; Scheidell, et al., 2018; Weiss, et al., 2018). One study found in a sample of 132 
participants, a correlation between addiction severity and emotional trauma severity and 
PTSD symptomology (Kuksis, et al., 2017). The present study aims to provide further insight 
into predictors of substance use treatment outcomes, particularly as it relates to women and 
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those who have experienced trauma, as well as discerning the effect of age and trauma type 
on these outcomes. 
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CHAPTER TWO: LITERATURE REVIEW 
 
Substance Use Treatment 
 
Substance Use Disorders are related to habitual and compulsive use (Cooper, Frone, 
Russel, & Mudar, 1995; Kuntsche, Knibbe, Engels, & Gmel, 2010). Development of SUDs 
and motivations for substance misuse are related to both positive and negative reinforcement: 
pleasure seeking and relief from other issues (Cooper, et al., 1995; Verheul, van den Brink, & 
Geerlings, 1993). Substance use can be used as a coping strategy to deal with problems, which 
results in dependent and problematic use (Folkman & Lazarus, 1988; Wong, et al., 2013). One 
study investigated the differences in common coping strategies among patients with SUDs 
with co-occurring mental health diagnoses, such as avoidant coping, palliative coping (i.e. 
breathing exercises, relaxation techniques), passive coping, active problem solving, and 
socialization (Kronenberg, Goossens, Busschback, Achterberg, & van den Brink, 2015). 
Avoidant coping, or disengagement coping, is an adverse coping strategy in which substances 
are used to avoid dealing with other stressors or issues in a person's life and is associated with 
negative treatment outcomes (Blomqvist, 1999; Folkman & Lazarus, 1988; Hasking, Lyvers, 
& Carlopio, 2011; Kronenberg, et al., 2015). Palliative coping is a strategy in which  
substances are used to feel better about problems. Passive coping is associated with rumination 
and retreating from problems. Positive coping strategies for dealing with SUDs are active 
problem solving and socialization, or seeking help from others (Kronenberg, et al., 2015). 
Thus, substance use can itself be a coping strategy that results in maladaptive behaviors and 
substance misuse, precipitating a need for treatment. 
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The goal of substance use treatment is to achieve abstinence or at a minimum reduce 
substance use and its adverse effects, such as poor personal health, interpersonal relationships, 
and overall functioning. There is some inconsistency in how to define remission in terms of 
substance use itself. Historically, abstinence has been the primary SUD treatment goal 
(Mignon, 2015). Some research has indicated that "controlled drinking" or drug moderation 
management, in which problem use can be reduced and social use is made possible, may be 
effective for some with SUDs (Heather & Dawes, 2005). For milder cases, or those without 
criteria indicating a more chronic condition, moderation may be a logical initial goal for 
treatment. However, abstinence is still the standard for most SUD treatment programs and is 
most appropriate for those with indications of a chronic condition (Kilpatrick, et al., 1978; 
Kopak, Proctor, & Hoffmann, 2014). Thus, treatment goals are not the same for every 
individual with a SUD. 
Level of Treatment 
 
There are many types of substance use treatment. There is acute treatment, such as 
detoxification, which focuses on the short-term goal of removing toxins from substances in 
the bloodstream and overcoming possible medical complications through monitoring the 
individuals’ conditions as they recover from acute use. This treatment often occurs in 
hospitals. Medical detoxification involves trained staff who monitor this process to avoid 
complications, such as seizures, during detoxification. This treatment is especially helpful for 
those who have been using substances for an extended period of time or have engaged in 
excessive use (Mignon, 2015). There are many risk factors associated with unsupervised 
detoxification. For example, immediate withdrawal for severe and or long-term use, without 
proper monitoring and medical treatment, is associated with high mortality rates (Mignon, 
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2015). Withdrawal does not always cause severe symptoms and is different across each 
substance. For example, heroin withdrawal is typically much more severe than cannabis 
withdrawal (Darke, Larney, & Farrell, 2017; Rogerson & Jacups, 2016). On the other hand, 
withdrawal from alcohol can be more dangerous or life threatening than withdrawal from 
heroin or other opiates (Trevisan, Boutros, Petrakis, & Krystal, 1998). 
Another level of acute treatment is inpatient, or residential. Detoxification is often a 
part of this treatment. However, the primary focus is not the physical withdrawal, but 
rather “rehabilitation” from the psychological dependence and adverse behaviors resulting 
from substance use (Mignon, 2015). This treatment typically lasts about a month, though it 
can be longer (McNeese-Smith, Faivre, Grauvogi, Warda, & Kurzbard, 2014). Inpatient 
treatment is often associated with more severe SUDs, previous suicidal ideation and 
attempt history, and is typically much more intensive than outpatient or community 
treatment (Budde, Rounsaville, & Bryant, 1992; Manhapra, Stefanovics, & Rosenheck, 
2015). Positive outcomes are associated with inpatient treatment, such as self-efficacy, 
effective coping strategies, participation in self- help groups, and abstinence. However, 
those in inpatient treatment who struggle with heroin and opioid misuse are at a higher risk 
of overdose, in many cases due to loss of tolerance (Schuman- Olivier, Greene, Bergman, 
& Kelly, 2014; Strang, et al., 2003). In recent years, medication assisted treatment (MAT) 
has become more prevalent, with some research suggesting that medications such as 
methadone, buprenorphine, and naltrexone are associated with better treatment outcomes 
in conjunction with other treatment such as outpatient care, despite some stigma 
surrounding the practice (Desmarais, et al., 2016; Littrell, 2017; Mohlman, Tanzman, 
Finison, Pinette, & Jones, 2016; NIH, 2016; Robinson & Adinoff, 2018). MAT is also 
used in treating the chronic use and withdrawal symptoms of other substances, such as 
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alcohol with the aid of the medications such as naltrexone, Acamprosate, and disulfiram 
(Desmarais, et al., 2016; Stein, et al., 2017). 
The last main level of substance use treatment is outpatient. It is the most commonly 
used, as it is less time-constrictive and easier to utilize for those with limited resources and 
who maintain employment (Mignon, 2015). It is typically much longer than inpatient, usually 
lasting between 60-120 days (McNeese-Smith, et al., 2014) Self-help groups, such as 
Alcoholics Anonymous (AA) and Narcotics Anonymous (NA), are support systems led by 
those in recovery that can improve treatment outcomes following treatment (Hoffmann, 
Harrison & Belille, 1983; Zywiak, Hoffmann, & Floyd, 1999). Attendance to self-help groups 
such as AA are associated with positive outcomes, such as treatment satisfaction, lowered risk 
of relapse, decreased mental health symptomology, self-efficacy, effective coping skills, and 
positive social support (Kendra, Weingardt, Cucciare, & Timko, 2015; Walton, Blow, & 
Booth, 2001). Additionally, engaging in treatment aftercare has also been associated with 
positive outcomes (Harris, Humphreys, Bowe, Kivlahan, & Finney, 2009; McLellan, et al., 
2005b; Schaefer, Cronkite, & Ingudomnukul, 2004). 
Predictors of Treatment Outcomes 
 
There are many correlates and predictors of substance use treatment outcomes. Treatment 
retention is associated with completion and other positive outcomes, such as long-term 
abstinence (Cunningham, 2005). Unfortunately, an overwhelming majority of those with 
substance use issues do not seek treatment (Burton & Williamson, 1995; Cunningham, 
2005; Cunningham & Breslin, 2004). One national survey collected data from 5,730 
people in the general population with a DSM-IV categorized Alcohol Abuse Disorder or 
Alcohol Dependence Disorder. Less than 13% of those who responded had ever sought 
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any type of substance use treatment, including self-help groups, emergency room visits, 
and medical doctor visits. Those who did engage in substance use treatment reported 
higher abstinence rates as well as lower binge-drinking rates than most of the sample that 
had not. (Cunningham, 2005). Common factors for those who do not seek treatment are 
financial limitations, inability to access care, stigma associated with substance use, lack of 
readiness to address addiction, and lack of prioritization of treatment (Ali, Teich, & 
Mutter, 2016). 
Another predictor of positive outcomes is length of treatment: longer participation is 
associated with lowered risk of relapse (Condelli & Hubbard, 1994; Hubbard, Craddock, & 
Anderson, 2003). Admission to SUD treatment, however, is not predictive of positive 
outcomes. The rate of patient drop-out from SUD treatment is high as well as the risk of 
relapse (Laudet, 2003; Simpson, 1979). Prematurely leaving treatment elevates the risk of 
relapse (Gordon, et al., 2009) as well as mortality rates (Decker, Peglow, Samples, & 
Cunningham, 2017). 
There are many common factors related to negative treatment outcomes. For example, 
some personality traits are indicative of poor treatment outcomes. Research suggests that high 
impulsivity prior to admission to treatment is associated with poor treatment retention and 
post- treatment abstinence (Loree, Lundahl, & Ledgerwood, 2015). Studies on the Big Five 
personality traits (Openness to Experience, Conscientiousness, Extraversion, Agreeableness, 
and Neuroticism) in substance use treatment clients indicate that impulsivity is associated with 
substance use dependence and chronic use, which may explain why these individuals are more 
likely to experience adverse treatment outcomes (Delic, Kajdiž, & Pregelj, 2016; Kotov, 
Gamez, Schmidt, & Watson, 2010; Lackner, Unterrainer, & Neubauer, 2013). Also, it is 
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common for those who experienced more adverse outcomes from SUDs to enter treatment. 
However, participation and engagement can be problematic for this population, sometimes 
resulting in treatment dropout (Burton & Williamson, 1995). Other common predictors of 
relapse include legal problems, criminal justice involvement, homelessness, younger age, 
family stability, low socio-economic status, lack of social support, unemployment, and SUD 
severity (Dobkins, Civita, Paraherakis, & Gill, 2002; Flannagan & Briggs, 2015; Harrison & 
Asche, 1999; Kopak, Haugh, & Hoffmann, 2016a; Kopak, Hoffmann, & Proctor, 2015; 
Kopak, et al., 2016b; Van Straaten, et al., 2016). Comorbid disorders, polysubstance use, and 
psychiatric hospitalizations are also common predictors of relapse and treatment drop out 
(Branson, Clemmy, Harrell, Subramaniam, & Geetha 2012; Decker, et al., 2017; Kreyenbuhl, 
Nossel, & Dixon, 2009; Ullman, Najdowski, & Filipas, 2009). In addition, monitoring those 
who have completed treatment is especially important for those with a chronic history of 
severe SUDs, as they may always be at a higher risk of relapse without proper 
support (Humphreys & Tucker, 2002). 
 
Moreover, there are also predictors of positive treatment outcomes. Some studies 
found that age is a predictor of successful treatment outcomes; older SUD patients are more 
likely to be successful than younger SUD patients (Brennan, Nichol, & Moos, 2003; Kopak, 
Hurt, Proctor, & Hoffmann, 2016c). Another predictor of retention and long-term remission is 
positive social support (Dobkins, et al., 2002). Marriages and long-term relationships are 
associated with positive treatment outcomes (Beattie, 2001; Heinz, Wu, Witkiewitz, Epstein, 
& Preston, 2009; Kopak, et al., 2015). Employment is also a positive indicator of successful 
treatment outcomes (Sahker, Acion, & Arndt, 2015; Wickizer, et al., 1994). In essence, there 
are many well-known demographic predictors of treatment outcomes. 
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Treatment Challenges and Barriers 
 
To ascertain treatment outcomes for those who have undergone substance use 
treatment, providers follow up with patients following completion. However, research has 
indicated that standard follow-up monitoring procedures may not be effective in both 
ascertaining accurate information and providing additional assistance for these individuals. 
This procedure is often performed by clinical staff contacting former patients at 1 month, 6 
month, and or 12 month intervals following treatment (Dobkins, et al., 2002; McNeese- 
Smith, et al., 2014; Schuman-Olivier, et al., 2014). One factor that may impact the efficacy 
of this process is a multitude of complicating, outside factors that cannot be controlled for 
as well as the financial cost and need for resources, such as trained clinical staff 
(McLellan, McKay, Forman, Cacciola, & Kemp, 2004). Furthermore, most follow-ups 
after treatment completion are based on self-report. There are conflicting results in the 
literature regarding the reliability of self-reports, with some findings indicating that they 
are (Calhoun, et al., 2000; Darke, 1998), and some indicating that they are not (Timko, et 
al., 2016). One study found that self-reports are more reliable and more consistent with 
others’ reports of the individual when the questions are more concrete, and the experiences 
and events are more memorable (Hoffmann & Ninoneuvo, 1994). 
In contrast, mutual-help groups such as AA and NA are considered to be effective 
monitoring treatment for those who have completed treatment. They also encourage 
seeking formal treatment for those with no previous treatment history (Hodges, Markward, 
Keele, & Evans, 2003; McLellan, et al., 2004; Weisner, Delucchi, Matzger, & Schmidt, 
2003a; Weisner, Matzger, & Kaskutas, 2003b). Although treatment is associated with 
positive outcomes, there are many barriers to treatment, both systemic and individual. 
Common individual predictors are poor patient motivation, lacking readiness for change, 
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lack of problem recognition, and no perceived need for help (Laudet, 2003; Laudet, 
Stanick, & Sands, 2009). Treatment satisfaction is another major obstacle to seeking 
treatment as well as treatment retention. One study examined the reasons that 250 patients 
left SUD treatment. Common reasons were dissatisfaction with clinical staff, scheduling 
difficulty, and unmet social service needs (Laudet, et al., 2009). The amount of time it 
takes for those with SUDs to receive treatment services decreases treatment satisfaction, 
which by proxy, also decreases utilization and effectiveness of treatment (Marsden, 
Ogborne, Farrell, & Rush, 2000). One way to increase treatment satisfaction is to include 
SUD patients in the treatment decisions. Other factors that increase satisfaction are policy 
clarity, peer support, and structure (Kasprow, Frisman, & Rosenheck, 1999). 
Furthermore, building trust between patients and treatment providers is especially 
important in increasing patient satisfaction for those with severe SUDs and Mental Health 
Disorders (MHDs) (Bohnert, Zivin, Welsh, & Kilbourne, 2011). Some research suggests 
that the patient-clinician relationship is more important than treatment modalities for 
positive outcomes (Miller, Mee-Lee, Plum, & Hubble, 2005). The assessment of patient 
satisfaction is essential to increasing treatment rates, retention, and positive outcomes 
(Kendra, et al., 2015; Manary, Boudling, Staelin, & Glickman, 2013; Villafranca, McKeller, 
Trafton, & Humphreys, 2006). In essence, there are several known barriers to treatment and 
predictors of treatment outcomes. 
Treatment Efficacy for Women 
 
Early research found that Substance Use Disorders were exponentially more 
prevalent in men than women (Robins & Regier, 1991). Recent research, however, 
indicates that the gap in reported substance use across the genders is closing at an alarming 
12  
rate, with rates of SUDs for women rising and remaining stable for men (Grucza, Bucholz, 
Rice, & Bierut, 2008; Grucza, Norberg, Bucholz, & Bierut, 2008; SAMHSA, 2012). Some 
research suggests that men and women have similar experiences with addiction and 
negative outcomes from SUDs (Alterman, Randall, & McLellan, 2003; Gerstein & 
Johnson, 2000). However, other research suggests that women may experience more 
adverse effects from substance use than men (Grella, et al., 2003; Hser, Huang, Teruya, & 
Anglin, 2004; McCrady & Raytek, 1993). Typically, women become intoxicated with 
smaller quantities of alcohol than men (Walter, Gutierrez, Ramskogler, Hertling, & Lesch, 
2003). Women are also more likely than men to have co- occurring mental health 
disorders, such as depression, anxiety, eating disorders, and trauma- related disorders, 
which is often associated with less positive treatment outcomes (Greenfield, et al., 2007; 
Pinchevsky, Wright, & Fagan, 2013). 
Additionally, women with SUDs are more likely than men with SUDs to have 
experienced childhood and adulthood trauma (McKay, et al., 2003; Pinchevsky, et al., 2013). 
Women with Alcohol Use Disorders are more likely to have resulting medical issues, such as 
liver problems (Bradley, Badrinath, Bush, Boyd-Wickizer, & Anawalt, 1998; Walton, et al., 
2001). The mortality rates for women with alcohol use are much higher than their male 
counterparts (Walter, et. al, 2003; Walton, et. al, 2001; United States Department of Health 
and Human Services & National Institute on Alcohol Abuse and Alcoholism, & NIAAA, 
2015). In contrast, women with SUDs experience less exposure to substances than men, have 
fewer negative social influences, and may have stronger coping skills (Walton, et al., 2001). 
Furthermore, there are differences in both Substance Use Disorder 
development and treatment outcomes between men and women (Greenfield, Back, 
13  
Lawson, & Brady, 2010). Women with SUDs are at a higher risk of the telescoping 
effect: shorter time intervals between first use, then risky use, then dependence, then 
treatment. In addition, women with SUDs have higher rates of clinical distress, severe 
medical and co-occurring 
mental health issues, and interpersonal problems. (Choo, et al., 2014; Hernandez-Avila, 
Rounsaville, & Kranzler, 2004; Piazza, et al., 1999). Also, compared to men, women face 
more treatment barriers (Greenfield, et al., 2007). Women are more likely to have less 
education, lower socio- economic status, more family responsibilities such as child care, 
custody concerns, and pregnancy, which are all indicative of poorer treatment outcomes 
(Bernstein, et al., 2015; Fox, Oliver, & Ellis, 2013; Hecksher & Hesse, 2009; Zilberman, 
Tavares, Andrade, & El- Guebaly, 2003). 
In contrast to established research, marriage is not as strong of a predictor for 
positive outcomes for women than men; this indicates that they may receive less support 
from their partners than their male counterparts and that it is more likely that their spouse 
will leave the relationship when the woman is the substance misuser (Walitzer & Dearing, 
2006). The self-in- relation theory states that relationships are very important to the 
psychological development and well-being of women such that women see these 
relationships as part of their self-concept, indicating that support from loved ones is crucial 
to recovery, which further indicates that the lack of support for women with SUDS is 
harmful to their recovery (Covington & Surrey, 1997; Manhal-Baugus, 1998). In addition, 
most current SUD treatment providers do not offer services many women need, such as child 
care and services for pregnant women (Berstein, et al., 2015). Women are also more likely to 
wait for significant longer periods to enter treatment than men, which may be due to both 
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systemic bias and personal characteristics such as perceived passivity in women who are 
seeking treatment (Downey, Rosengren, & Donovan, 2003). 
Despite these barriers, approximately one third of those seeking substance use 
treatment are women (Brady & Ashley, 2005). Women are also more likely to 
complete treatment than men (Kosten, Gawin, Kosten, & Rounsaville, 1993). 
However, women are less likely than men to seek help from a formal SUD treatment 
program and more likely to seek treatment from less effective providers, such as a 
primary care physician or solely acute medical SUD treatment; this is likely due to the 
stigma associated with women who have SUDs (Bernstein, et al., 2015; Hecksher & 
Hesse, 2009; Green, 2006) This stigma is related to the more severe social 
consequences women experience as compared to men (Bradley, et al., 1998). 
Unfortunately, women have long been underrepresented in substance use treatment 
research (Timko, et al., 2016). Recent research indicates that women who complete treatment 
are more likely to have positive outcomes, such as long-term remission, as compared to men 
(Kosten, et al., 1993). However, there are concerns that the current treatment modalities are 
not as effective for women as they are for men. While some of the research indicates that men 
and women have similar treatment success rates (Gerstein & Johnson, 2000; Greenfield, et al., 
2007), other studies have found that long-term posttreatment outcomes may differ between 
genders (Hser, et al., 2004; McCrady & Raytek, 1993). The literature is also mixed in terms of 
whether men and women have similar treatment success rates. indicating that gender may not 
be the best predictor of treatment outcomes. However, other secondary factors in women with 
SUDs have been associated with positive outcomes such as coping and resilience (Asberg & 
Renk, 2012; Banyard & Williams, 2007; Walton, et. al., 2000) while other have been 
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associated with negative outcomes such as co-occurring MHDs and psychological distress 
(Kranzler & Tinsley, 2004). 
Like research on Substance Use Disorder development, rates, and consequences for women, 
there has been a historic lack of focus on specialized treatment for this population (Trepper, 
Nelson, McCollum, & McAvoy, 1997). In particular, previous research on women- only 
(WO) substance use treatment was minimal (Sugarman, et al., 2006). Recent research has 
found that many women report that they prefer WO treatment, as they feel that it is a more 
comfortable environment (Copeland & Hall, 1992; Sugarman, et. al, 2016). Also, women 
are typically less comfortable discussing trauma related issues in mixed-gender (MG) SUD 
treatment, are more likely to withdraw from group discussions, and to have adverse 
treatment experiences such as feelings of guilt and failure (Hodgins & El-Guebaly, 2007; 
Nelson-Zlupko, Dore, Kauffman, & Kaltenbach, 1996). While there have been some studies 
that have found no differences in treatment retention between WO treatment and MG 
treatment (Bride, 2001; Niv & Hser, 2007), other research has found that retention rates are 
higher in WO programs, particularly for those with more severe SUDs (Zilberman, et al., 
2003). 
In addition, women who have experienced childhood sexual trauma, are of a sexual 
minority, and have children are all more likely to prefer WO substance use treatment 
(Copeland & Hall, 1992). Women who prefer WO treatment are more likely to have had 
prior SUD treatment, to have more severe symptoms and adverse experiences, to be 
pregnant, homeless, and have either current or previous involvement in the Criminal Justice 
System (Grella, 1999). Further, they are more likely to have experienced recent physical 
trauma, especially those in inpatient treatment (Niv & Hser, 2007). Some benefits of WO 
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substance use treatment are higher rates of treatment completion, less perceived 
discrimination due to gender, and education on issues that are specific to women, such as 
child care, pregnancy, trauma, etc. (Copeland & Hall, 1992). For instance, one longitudinal 
study included 789 women, either pregnant or with children, who completed substance use 
treatment in California. They were in either WO or MG treatment. Treatment outcomes 
were followed up at 8 and 10 years after program completion. Those who received women- 
only treatment were less involved in the criminal justice system (Evans, Li, Pierce, & Hser, 
2013). One substance use treatment program for women that found that trauma may be a 
moderator between outcomes and gender is Stephanie Covington’s Beyond Trauma: A 
Healing Journey for Women (Ackley, 2011). 
Thus, MG substance use treatment is not as effective as WO treatment for many 
women in recovery (Greenfeld, et al., 2007; Sugarman, et al., 2016). Despite this, only 32% of 
substance use treatment centers offer specialized services for women (SAMHSA, 2012). In 
essence, there are many established treatment barriers for women with Substance Use 
Disorders. However, further research is needed on SUD development, predictors of treatment 
outcomes, and on effective treatment modalities for this population. 
Trauma and Treatment Outcomes 
 
Co-occurring Mental Health Disorders and Substance Use Disorders are related to a 
higher risk of negative treatment outcomes (Kreyenbuhl, et al., 2009; Norman, et al., 
2007). The American Psychological Association (APA) defines trauma as an emotional 
reaction to an adverse event, such as sexual assault or physical abuse (2013). Trauma often 
manifests in mental health symptoms that impair a persons’ well-being and functioning, 
such as anxiety and depression, and have been associated with other issues such as eating 
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disorders (APA, 2013; Edman, Watson, & Patron, 2016). Trauma history and 
symptomology are common in those with SUDs (Giordano, et al., 2016). Some groups in 
treatment are at a higher risk than others for this comorbidity, such as women and 
homeless populations (Asberg & Renk, 2016; Flannagan & Briggs, 2015; Van Straaten, et 
al., 2016). Those who have experienced trauma are at a higher risk of treatment dropout 
and post treatment relapse (Gil-Rivas, Prause, & Grella, 2009; Simpson, 1979). In 
addition, those with a history of trauma are at a higher risk of severe SUD symptoms, 
which further increase the likelihood of adverse treatment outcomes (Brown & Anderson, 
1991; Gibson & Leitenberg, 2001; Moncrieff & Farmer, 1998; Schuck & Widom, 2001). 
Trauma is linked to substance misuse, as those who have more adverse experiences are 
more likely to engage in risky behaviors and experience negative outcomes (Clark, 
Zyambo, Li, & Cropsey, 2014; Sharp, Peck, & Hartsfield, 2012). Substance use tends to 
increase when symptoms and life stressors are severe; this is related to increased reactivity 
to stress. (Lijiffijit, Hu, & Swann, 2014). 
In terms of trauma’s impact on substance misuse, research suggests that craving 
increases when Substance Use Disorder patients are confronted with trauma, or cue-reactive 
craving (Banducci, Bumarski, Bonn-Miller, Patel, & Connolly, 2016; Coffey, et al., 2002; 
Waldrop, Back, Verduin, & Brady, 2007). This may be why many have argued that trauma 
should not be a focus of SUD treatment (Potthast & Catani, 2012). However, some research 
has indicated that trauma-focused therapy, notably from women-focused studies, can be 
effective and not cause adverse reactions (Coffey, Stasiewicz, Hughes, & Brimo, 2006; Hien, 
et al., 2010a; Najavits, Schmitz, Gotthardt, & Weiss, 2005; Toussaint, VandeMark, 
Bornemann, & Graeber, 2007; van Dam, Ehring, Vedel, & Emmelkamp, 2013). One theory 
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suggests that when hyper arousal associated with traumatic events is triggered by external 
events after release from treatment, relapse may occur, which suggests that addressing trauma 
in treatment could act as a preventative measure (Gerwe, 2010). Other studies have found that 
dialectical behavior therapy (DBT) can be an effective form of treatment for those with MHD 
and SUD comorbidity (Courbasson, Nishikawa, & Dixon, 2012; Brown & Dahlin, 2017; Lee, 
Cameron, & Jenner, 2015). Thus, it is unlikely that there is a global negative effect of trauma 
and SUD symptoms; the variability in outcomes may be due to outlying factors, such as 
demographics (Brown, 2003; Hofler, Gloster, & Hoyer, 2010). 
Posttraumatic Stress Disorder is highly prevalent in the Substance Use Disorder 
population (Driessen, et al., 2008; Ouimette, Brown, & Najavits, 1998; Schäfer & Najavits, 
2007). One meta-analysis study found that one-third of SUD patients in 22 different studies 
met criteria for PTSD (Hildebrand, Behrendt, & Hoyer, 2015) Many of these studies have 
veteran samples (Back, et al. 2014; Banducci, et al., 2016; Decker, et al., 2017; Ouimette, 
Moos, & Brown, 2003). In addition, one national epidemiologic study found that 46.4% of 
those with PTSD had a co-occurring SUD, (Pietrzak., Goldstein, Southwick, & Grant, 2011). 
Those with PTSD symptomology are less likely to develop effective strategies for coping with 
stress and are more likely to engage in excessive substance use, which affects their brain 
circuitry (Brown, 2003; Chilcoat & Breslau, 1998). 
Moreover, research has indicated that substance misuse and SUD development in those 
with severe co-occurring MHDs, such as PTSD, is related to self-medication; this coping 
strategy has been associated with short-term relief from other symptoms, which results in 
higher rates of habitual and dysfunctional use (Chilcoat & Breslau, 1998; Khantzian, 1985; 
Khantzian, 1997; Miranda, Meverson, Long, Marx, & Simpson, 2002; Tronnier, 2015). One 
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factor that may be related to self-medication is the epigenetic influence that certain substances 
have. For example, nicotine and alcohol may increase reactivity to illicit substances such as 
cocaine; higher reactivity to substances increases the risk of substance misuse, particularly if 
the intent of use is to relieve mental health symptoms (Jordan & Anderson, 2016; Levine, et 
al., 2011). Avoidance coping has also been associated with trauma histories (Bal, Crombez, 
Van Oost, & Debourdeaudhuij, 2003; Kendall-Tackett, Marshall, & Ness, 2000). Research 
has also found that there may be a relationship between SUD development and PTSD, as 
those who engage in excessive substance use may engage in more risky behaviors, thus 
increasing the probability for exposure to traumatic events (Haller & Chassin, 2014). 
Unfortunately, many individuals with co- occurring trauma and SUD do not feel comfortable 
disclosing, due to feelings of self-blame, shame, and fear of alienation from their loved ones 
(Bonnan-White, Hetzel-Riggin, Diamond-Welch, & Tollini, 2018; Schumm, Koucky, & 
Bartel, 2014). 
In addition, co-occurring PTSD and SUD diagnoses are associated with poorer 
treatment outcomes and barriers to treatment (Driessen, et al., 2008; López-Castro, Hu, 
Papini, Ruglass, & Hein, 2015; Ouitmette, et al., 1998). Those who do not meet the criteria 
for PTSD but have related symptoms are also at risk for adverse treatment outcomes 
(Norman, Tate, Anderson, & Brown, 2007). There is some research that found that PTSD 
symptoms of those with co- occurring SUDs negatively impacted their ability to benefit from 
SUD treatment (Ouimette, et al., 1998; Schäfer & Najavits, 2007). Common risk factors for 
this population are low socio- economic status, feelings of guilt and shame, interpersonal 
problems, and avoidance coping (Vujanovic, Bonn-Miller, & Petry, 2016). Other risk factors 
for those with co-occurring SUDs and PTSD were poor interpersonal relationships and life 
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stressors (Brown, Read, & Kahler, 2003; Gil-Rivas, et al., 2009; Ouimette, Coolhart, 
Funderburk, Wade, & Brown, 2007; Read, Brown, & Kahler, 2004). Research suggests that 
craving and active discomfort is more prevalent in those with PTSD and PTSD related 
symptoms than others in the substance use treatment population (Kaczkurkin, Asnaani, 
Alpert, & Foa, 2016; Kaysen, et al., 2014; Proctor, Llorca, Perez, & Hoffmann, 2016; Tripp, 
et al., 2015) One study found that craving in SUD-PTSD patients was related to distress, 
nightmares, emotional numbing, and hypervigilance (Simpson, Stappenbeck, Varra, Moore, 
& Kaysen, 2012). 
Furthermore, some research has indicated that those with co-occurring SUDs and 
MHDs who are in treatment for one may experience "spillover effects" of improvement in the 
other domain that is not being targeted in treatment (Ramchand, Griffin, Slaughter, Almirall, 
& McCaffrey, 2014). However, some studies show that those with comorbid MHDs who seek 
substance use treatment often do not experience a reduction in symptoms for both issues 
(Back, Brady, Sonne, & Verduin, 2006; McCauley, Killeen, Gros, Brady, & Back, 2012). 
Other research has found that SUD treatment can reduce symptoms of co-occurring mental 
health concerns, notably PTSD and trauma (Back, et al., 2006; Coffey, et al., 2002; Gossop, 
Marden, & Stewart, 2006; Herzog, et al., 2016; Hien, et al., 2010b; McCauley, et al., 2012; 
Nosen, Littlefield, Schumacher, Stasiewicz, & Coffey, 2014). In addition, one study found 
that reduction in SUD symptoms preceded PTSD symptom reduction (Back, et al., 2014). 
Informal treatment has been associated with positive outcomes as well. Those with co- 
occurring MHDs, including PTSD and PTSD symptomology, benefit from mutual-help 
groups such as AA (Kendra, et al., 2015; Magura, 2008). 
In terms of trauma prevalence, both childhood trauma and adulthood trauma are common in 
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SUD patients and are associated with a higher risk of treatment dropout and relapse (Brady, 
et al., 2004; Jacobsen, et al., 2001; Wu, Schairer, Dellor, & Grella, 2010). Women are more 
likely to report both sexual and physical trauma histories as compared to men (Brems, 
Johnson, Neal, & Freemon, 2004). Other studies have indicated that women experience both 
sexual and physical abuse at a higher rate than men (Brown & Anderson, 1991; Cosden, 
Larson, Donahue, & Nylund-Gibson, 2015). There is an abundance of research that has 
explored associations between childhood trauma and substance misuse. There have been 
several studies indicating that childhood sexual abuse (CSA) is associated with substance 
misuse, many of which used a female sample (Galaif, et al., 2001; Ireland, Smith, & 
Thornberry, 2002; Wilsnack, Vogeltanz, Klassen, & Harris, 1997). For example, one study 
found that females who experienced CSA are ten times more likely to report drug misuse 
and two times more likely to report alcohol misuse than those who had not (Briere & Runtz, 
1989). Childhood physical trauma is also associated with substance misuse (Cosden, et al., 
2016: Giordano, et al., 2015). In addition, there have been several studies indicating that 
adulthood physical trauma, such as intimate partner violence, is associated with substance 
misuse (Afifi, Henriksen, Asmundson, & Sareen, 2012; Low, Tiberio, Shortt, Capaldi, & 
Eddy, 2017). Research has also indicated that adulthood sexual trauma is related to adverse 
outcomes (Resnick, Walsh, Schumacher, Kilpatrick, & Acierno, 2013; Schumm, Hobfoll, & 
Keogh, 2004). 
In contrast, there is a paucity of studies that have investigated differences across both 
age and type of trauma in relation to treatment outcomes. There are some studies that compare 
the difference in type of trauma and outcomes associated with them, such as Brems’ 2004 
study and Giardano’s 2016 study, which both looked at physical and sexual trauma in male 
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and female participants. Another study investigated three different types of childhood trauma 
and their association with alcohol and drug dependence in a sample of 22,544 persons: sexual 
abuse, physical abuse, and exposure to parental domestic violence. All three types were found 
to be predictors of substance dependence (Fuller-Thomson, Roane, & Brennenstuhl, 2016). 
There have also been studies that investigated the age at which trauma was experienced, which 
have indicated that those who have experienced childhood trauma are at risk of revictimization 
as an adult (Cannon, Bonomi, Anderson, Rivara, & Thompson, 2010; Widom, Czaja, & 
Dutton, 2008), thus experiencing similar negative treatment outcomes. 
In essence, trauma is prevalent in those with Substance Use Disorders and is associated with 
negative outcomes. Polyvictimization, when a person experiences different types of trauma 
(e.g., physical, sexual) is also common in those who experience substance use problems 
(Barnes, Howell, & Miller-Graff, 2016; Voisin, 2013). Thus, it is imperative that those 
entering SUD treatment be screened and evaluated for trauma symptomology and trauma 
history as they frequently co-occur within the population and are predictive of outcomes 
(Ouitmette, et. al, 1998). It would be beneficial to investigate the interactions of age and type 
of trauma further in substance use treatment populations. Addressing trauma in SUD treatment 
may decrease the risk of relapse and other adverse outcomes. 
The Present Study 
 
Previous research has found various predictors for substance use treatment outcomes. 
 
There is a wealth of literature on correlates of treatment dropout and posttreatment relapse. 
However, there is a distinct gap in the research on treatment outcomes for women. While 
gender has not been found to be a predictor in and of itself of treatment outcomes, there are 
distinct differences between predictors for outcomes of men and women. Much of what has 
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been done to investigate women’s needs in substance use treatment has been done very 
recently. It is mixed in terms of what factors are indicative of negative or positive outcomes 
and what is effective treatment. The majority of studies have included very few women and 
have almost always used mixed-gender treatment samples. This is relevant, as some research 
suggests that women- focused substance use treatment is more effective than mixed-gender 
treatment. Similarly to gender, too little research has been done to efficiently investigate 
trauma and its role in substance use treatment. There have also been recent studies conducted 
that investigated trauma- focused substance use treatment, such as Seeking Safety. However, 
the literature continues to be mixed in terms of whether treating trauma or other mental health 
issues is effective in substance use treatment. Another issue with the current research on 
trauma and treatment outcomes is its variability in what trauma is investigated; there has been 
a historic focus on childhood sexual abuse and physical abuse, but not as much on adulthood 
physical trauma outside of Interpersonal Violence, for example. Thus, the present study seeks 
to examine the role of trauma itself, polyvictimization, and revictimization on treatment 
outcomes. 
Hypotheses 
 
The present study explores the following hypotheses: 
 
Hypothesis 1 
 
Previous research has suggested that trauma history is associated with severe SUD 
symptomology, a predictor of negative treatment outcomes (Humphreys & Tucker, 2002; 
Ouimette, et al., 2003). Thus, women who have experienced physical or sexual trauma will 
have more negative treatment outcomes than women who have never experienced trauma: 
relapse and re-entry into treatment. 
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Hypothesis 2 
 
Research has indicated that polyvictimization is indicative of severe SUD 
symptomology, which is a predictor of negative treatment outcomes (Haller & Chassin, 2014). 
Thus, women who have experienced polyvictimization, two different types of trauma (e.g., 
physical, sexual), will have more negative treatment outcomes than those who have only 
experienced one type of trauma. 
Hypothesis 3 
 
Research indicates that both childhood and adulthood trauma are associated with 
negative treatment outcomes (Brady, et al., 2004; Jacobsen, et al., 2001; Wu, et al., 2010), 
thereby suggesting that those who have been revictimized, exposure to trauma earlier in life 
and again later in life, may have worse treatment outcomes than those who have experienced it 
once. Thus, women who have experienced revictimization will have more negative treatment 
outcomes than those who have only experienced childhood trauma or adulthood trauma. 
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CHAPTER THREE: METHOD 
Participants 
 
Data was collected from an archival database: The Comprehensive Addiction and 
Treatment Outcome (CATOR) system was used for the purposes of this study. The CATOR 
database is the largest independent evaluation service of substance use treatment programs 
across the United States. The purpose of this service was to ascertain whether treatment 
providers were successful in helping patients remain abstinent from substance use. The wealth 
of information that was collected from around 40,000 patients aided researchers in finding 
correlates of both positive and negative treatment outcomes. This data was collected in the late 
1980’s to the early 1990’s. There are about 4,000 female participants in the database that will 
be included in this study. These participants are between the ages of 18 and 65 years and are 
predominately white. 
Demographics 
 
Cross tabulations were conducted to determine demographic, clinical factors, and 
protective factors prevalence within the sample of the study. The sample was comprised of 
3,078 women, with an age range of 18 to 65 and an average age of 36.7 years. Regarding 
race, 87.0% of the sample was white and 13.0%% identified as any other race. The majority 
of the sample was employed at the time of their entrance into treatment (56.8%) and the 
unemployed group was similar in size (43.2%). A large majority was married (76.5%), while 
the rest reported being single (23.5%). The overwhelming majority of the sample reported 
graduating high school/receiving their GED in addition to higher education (92.1%), with 
only 7.9% reported less than a high school/GED education. The sample was almost evenly 
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split in terms of having dependent children under the age of 18 in their care: 50.7% did not. 
 
Clinical Factors 
 
Most of the sample reported experiencing trauma, with 65.0% indicating at least one 
type. Of those who experienced trauma, 28.7% reported physical trauma only, 60.4% 
reported sexual trauma only, and 10.9% reported polyvictimization. Additionally, 30.1% 
reported experiencing trauma only before the age of 18, 20.1% reported experiencing trauma 
only after the age of 18, and 49.9% reported experiencing revictimization. Many participants 
reported having at least five or more positive criterions of depression (67.5%) and the 
remainder reported no symptomology (32.5%). In contrast, only 15.8% met criteria for a 
DSM-IV eating disorder diagnosis. Around 32.9% met criteria for more than one substance 
abuse disorder or substance dependence disorder (DSM-IV). 
In terms of polysubstance use, 66% reported using 2 or more substances prior to 
admittance. Of those reporting use of two or more substances, 93% reported alcohol use, 45% 
reported cocaine use, 60% reported marijuana use, 30% reported stimulant use, and 12% 
reported opiate use. Recent use was determined based on whether the participants used 
substances in the 24 hours prior to treatment: 55.3% reported no recent use and 44.7% 
reported recent use. Injection was also measured based on whether participants used needles, 
with the majority not using needles (87.4%). Many participants reported experiencing one of 
more withdrawal symptoms upon admittance to treatment (51.6%). Treatment completion 
was higher than the national average, with 86.6% staying the full amount of time, which may 
be due to the programs’ confidence in their efficacy, thus prompting them to join this study 
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Protective Factors 
 
Of the entire sample, a large majority reported attending AA 6 months after 
their release from treatment (84.5%). Similarly, 62.9% reported engaging in treatment 
after-care 6 months after treatment. Only 32.3% reported attending other support 
groups besides AA 6 months after treatment. 
Measures 
 
The CATOR Intake/History/Discharge/Follow-Up Instruments 
 
Participating substance use treatment programs’ clinical staff administered the intake, 
history, and demographic forms to patients at intake and during the course of treatment. 
Trained follow-up interviewers employed by the independent organization operating the 
CATOR administered the follow-up form at 6 and 12 months over the telephone to former 
patients. This database includes question regarding demographic information, reason for 
treatment, diagnostic criteria, mental health concerns, and treatment outcomes. There are four 
items that ask about first-hand trauma. Table 1 in the appendices includes these items; the 
present study will explore trauma with these concrete definitions. 
 
The variables for the trauma items are coded dichotomously as 0 “no” or 1 “yes.” 
They were used to create trauma-groups: No Trauma, Physical Trauma Only, Sexual 
Trauma Only, Both Physical and Sexual Trauma (polyvictimization), Trauma before 18 
only, Trauma after 18 only, and Trauma before and after 18 (revictimization). Similarly, 
treatment outcomes are all coded as “0” and “1.” Relapse is coded as 0 for “did not relapse” 
and 1 for “relapsed” and Re-Entry into Treatment is coded as 0 for “did not re-enter” and 1 
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for “re-entered treatment.” This study investigated these outcomes at both the 6-month 
follow-up and the 12-month follow-up. 
Other variables that were included are demographics such as age, race, employment 
status, marital status, welfare status, and education, as well as protective factors such as AA 
attendance, support group attendance, and engagement in aftercare. Many of these variables 
are known demographic risk factors (age, employment, having dependent children, socio- 
economic status, and education). Mental health symptoms and clinical distress are also 
addressed with the following variables: depression, eating disorders, polysubstance use, 
recent use prior to admission, number of days used in week prior to admission, injection, 
withdrawal, number of SUD diagnoses, and premature discharge from treatment. These 
diagnoses are under DSM-IV categorization. However, research has found that previous 
dependence and abuse diagnoses from the DSM-IV are compatible with the current DSM-5 
diagnoses (Agrawal, Heath, & Lynskey, 2011; Boscarino, Rustails, Hoffman, Han, Erlich, & 
Ross, 2011; Kopak, Metz, & Hoffmann, 2014; Kopak, Proctor, & Hoffmann, 2016b; 
Proctor, Kopak, & Hoffmann, 2012). 
Statistical Analyses 
 
Cross-tabulations of independent variables (i.e. demographics, protective factors, 
clinical factors) were done to show the results in a way that is more communicable than 
other analyses. This is important, as the implications of the results will be more effectivity 
communicated to treatment providers. In this way, treatment providers can provide better 
informed services. To address the hypotheses, Chi-square Tests of Independences were 
conducted to compare group differences. Chi-Square tests were done to determine whether 
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hypothesis, as to whether trauma itself is associated with negative treatment outcomes 
 
This was done by condensing the trauma groups Physical Trauma only, Sexual Trauma 
only, and Both Physical and Sexual Trauma into one group and comparing it to the No 
Trauma group to measure whether trauma is associated with each of the treatment outcome 
variables. The next series of Chi-Square tests address the second hypothesis, as to whether 
polyvictimization (Both Physical and Sexual Trauma group) is associated with worse 
treatment outcomes than a single type of trauma. This was done by comparing the trauma 
groups Physical Trauma only, Sexual Trauma only, and Both Physical and Sexual Trauma 
to measure whether polyvictimization is associated with each of the treatment outcome 
variables. The third series of Chi-Square tests address the third hypothesis, as to whether 
revictimization (Trauma before and after 18) is associated with worse treatment outcomes. 
This was done by comparing the trauma groups Trauma before 18 only, Trauma after 18 
only, and Trauma before and after 18 to measure whether revictimization is associated with 
each of the treatment outcome variables. These analyses were done for both the 6 month 
follow-up and the 12 month follow-up. 
Logistical regressions were also conducted to address the first hypothesis, in that 
trauma is predictive of treatment outcomes. This was done at the 6 month follow-up and the 
12 month follow-up. This will determine the strength of trauma as a predictor of each 
treatment outcome variable against known predictors of treatment outcomes: age, marital 
status, employment, socio-economic status, education, having dependent children, co- 
occurring mental health diagnoses, polysubstance use, recent use prior to admission, number 
of days used in week prior to admission, injection, withdrawal, number of SUD diagnoses, 
and premature discharge from treatment. 
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CHAPTER FOUR: RESULTS 
 
Hypothesis 1 
 
To determine whether women who have experienced physical and/or sexual trauma 
will have more negative treatment outcomes (relapse and re-entry into treatment) than 
women who have never experienced trauma, Chi Square Tests of Independence were 
conducted to look at treatment outcome differences between the “Trauma” group and the 
“No Trauma” group. Both relapse and treatment re-entry at 6 months were investigated. The 
percentage of participants that relapsed did not differ by whether they had reported 
experiencing trauma, X2(1, N= 3, 078) =5.69 p = 0.017. See Table 2 in appendix. The 
percentage of participants that re- entered treatment did not differ by whether they had 
reported experiencing trauma, X
2
(1, N= 3,078) = 4.91, p = 0.027. See Table 3 in appendix. 
Both relapse and treatment re-entry at 12 months were also investigated. The percentage of 
participants that relapsed did not differ by whether they had reported experiencing trauma, 
X
2
(1, N= 3, 078) = 10.56 p = 0.001. See Table 4 in appendix. The percentage of participants 
that re-entered treatment did not differ by whether they had experienced trauma, X
2
(1, N= 3, 
078) = 5.94, p = 0.015. See Table 5 in appendix. 
 
To determine the strength of trauma as a predictive factor for treatment outcomes, 
logistical regressions were conducted, which included demographic risk factors, clinical risk 
factors, and protective factors at 6 and 12 months. It is important to note that many of the 
demographic risk factors are lopsided, such as ethnicity and education. For regressions at 12 
months, we included both treatment outcomes as variables. At 6 months, trauma was not 
predictive of relapse, OR = 1.01, 95% C.I. = 0.92-1.30. See Table 6 in appendix. Age, 
ethnicity, recent use, injection, and treatment completion were significant predictors. At 6 
31  
months, trauma was not predictive of re-entry into treatment, OR = 1.10, 95% C.I. = 0.81- 
 
1.47. Ethnicity injection, and the constant variable were significant predictors. See Table 7 
in appendix. At 12 months, trauma approached significant as a predictive factor of relapse, 
OR= 1.20, 95% C.I. = 1.01-1.43. See Table 8 in appendix. Employment, marriage status, 
depression, recent use, injection, AA attendance, support group attendance, after-care, and 
re-entry into treatment were significant predictors. At 12 months, trauma was not predictive 
of re-entry into treatment, OR = 1.02, 95% C.I. = 0.73-1.41. See Table 9 in appendix. Age, 
ethnicity, employment, marriage status, withdrawal, treatment completion, support group 
attendance, and relapse were significant predictors. Based on these results, trauma does not 
appear to be a strong predictive factor in treatment outcomes such as relapse and re-entry 
into treatment. 
Hypothesis 2 
 
To determine whether women who have experienced both physical and sexual 
trauma(polyvictimization) will have more negative treatment outcomes (relapse and re- 
entry into treatment) than women who have experienced only physical or only sexual 
trauma, Chi Square Tests of Independence were conducted to look at treatment outcome 
differences between the“Single Trauma” group and the “Both Physical and Sexual Trauma” 
group. The “Both Physical and Sexual Trauma” group was much smaller than the “Single 
Trauma” group, resulting in lopsided groups. Both relapse and treatment re-entry at 6 
months were investigated. The percentage of participants that relapsed did not differ by 
whether they experienced polyvictimization, X2(1, N= 3, 078) = 2.9, p = 0.089. See table 10 
in appendix. The percentage of participants that re-entered treatment did not differ by 
whether they experienced polyvictimization, X2(1, N= 3, 078)=1.1, p = 0.294. See Table 11 
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The percentage of participants that relapsed did significantly differ by whether they experienced 
polyvictimization: those who experienced only one type of trauma Those who experienced only 
one type of trauma were more likely to relapse, X
2
(1, N= 3,078) = 4.83 p = 0.028. See Table 12 
in appendix. The percentage of participants that re- entered treatment did not differ by whether 
they experienced polyvictimization, X
2
(1, N= 3,078) = 1.53, p = 0.216. See Table 13 in 
appendix. 
Hypothesis 3 
 
To determine whether women who have experienced trauma more than once 
(revictimization) will have more negative treatment outcomes (relapse and re-entry into 
treatment) than women who have experienced only childhood or adulthood trauma, Chi Square 
Tests of Independence were conducted to look at treatment outcome differences between the 
“Single Trauma” group and the “Both Physical and Sexual Trauma” group. Both relapse and 
treatment re-entry at 6 months were investigated. The percentage of participants that relapsed 
did not differ by whether they experienced revictimization, X2(1, N= 3, 078) = 2.02, p = 0.155. 
See Table 14 in appendix. The percentage of participants that re-entered treatment did not differ 
by whether they experienced revictimization, X2(1, N= 3, 078) = 2.46, p = 0.117. See Table 15 
in appendix. Both relapse and treatment re-entry at 12 months were also investigated. The 
percentage of participants that relapsed did significantly differ by whether they experienced 
revictimization: those who experienced trauma before and after 18 were more likely to relapse, 
X2(1, N= 3, 078) = 6.36, p = 0.012. See Table 16 in appendix. The percentage of participants 
that re-entered treatment did significantly differ by whether they experienced revictimization: 
those who experienced trauma before and after 18 were more likely to re-enter treatment, X2(1, 
N= 3,078) = 5.94, p = 0.015. See 17 in appendix. 
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CHAPTER FIVE: DISCUSSION 
 
The results of this study indicate that while trauma in and of itself may not be a strong 
predictor of relapse and re-entry into treatment, there is merit in identifying it in the course of 
treatment. To test the first hypothesis, group differences and the strength of trauma as a predictor 
were investigated. Chi Square Tests of Independence determined that there were no significant 
differences between participants who experienced trauma and those who had not in terms of 
relapse and re-entry into treatment at both 6 and 12 months after initial treatment. Logistical 
Regressions determined that trauma was not predictive of either treatment outcomes at 6 months. 
However, trauma approached significance as a predictor for relapse at 12 months. The literature 
on trauma and its impact on substance use treatment is mixed in terms of its relevance and on 
whether it should be addressed during treatment. However, it is important to note that trauma 
approaching significance for relapse at 12 months may indicate that it has a long-term impact on 
substance use; while 6 and 12 months post treatment results are commonly used and are a strong 
indicator of treatment success, significance at 12 months can indicate a stronger connection than 
significance at 6 months (Buckheit, Moskal, Spinola, Maisto, & Chung, 2018; Proctor, 
Wainwright, & Herschman, 2017). It is also important to note that while 12 month outcomes 
may be stronger than 6 months, it is more difficult to parse out whether relapse or re-entry into 
treatment is related to the efficacy of the first treatment or if it is another factor (Ham, Compton, 
Blanco, & Colpe, 2017; Sayegh, Huey, Zara, & Jhaveri, 2017). Trauma was not a significant 
predictor for re-entry into treatment at 12 months. 
While there were no significant group differences when trauma alone was 
investigated, there were some when testing the second hypothesis: polyvictimization and its 
impact on treatment outcomes. At 6 months, there were no significant differences for either 
relapse or 
 
trauma. However, at 12 months, there was a disparity in relapse between those who had only 
experienced one type of trauma, either physical or sexual, and those who had experienced 
polyvictimization. While the original hypothesis posited that the polyvictimization would likely 
indicate more negative outcomes than those who had experienced a single type of trauma, the 
Chi Square Tests of Independence indicate that the opposite is true. Those who belonged to the 
single trauma group were more likely to relapse than those who had experienced more than one 
type. This may be due to greater resilience fostered in those who have experienced 
polyvictimization than those who have only experienced on type of trauma (Wolfe, 2018). 
Additionally, those who had experienced multiple traumas may be more likely to have already 
sought mental health treatment prior to their intake, depending on the severity of the trauma 
(Moncrieff & Farmer, 1998; Schuck & Widom, 2001). There were no significant differences in 
re-entry to treatment at 12 months. 
To test the third hypothesis, that revictimization would be more associated with relapse 
and re-entry into treatment, Chi Square Tests of Independence were conducted. Similarly to the 
second hypothesis testing, there were no significant group differences in treatment outcomes 
between those who had experienced trauma before 18 or after 18 and those who had experienced 
revictimization, or both childhood and adulthood trauma. At 12 months, however, there were 
significant differences in both relapse and re-entry into treatment. For both outcomes, those who 
had experienced revictimization were more likely to experience them than those who had not. 
This is consistent with results from previous literature (Schumm, et al., 2004; Ullman, et al., 
2009). Thus, the 12 month outcomes were consistent with the third hypothesis. 
Each statistically significant finding was found at 12 months following treatment, which 
indicates that these findings are reflective of longer term outcomes. Additionally, there were 
 
significant findings or, for the first hypothesis, approaching significance findings when 
addressing relapse for all three hypotheses, which indicates a relationship with trauma 
and relapse as well as problem use. 
Limitations 
 
This database is over 30 years old, which suggests that substance use trends, 
methodology of treatment, the demographics of the participants, and many other factors may not 
reflect the current substance use treatment population. Additionally, there were only four 
questions that asked about sexual and physical trauma that defined the abuse in very narrow 
terms. Emotional trauma was not accounted for. These questions only asked whether abuse had 
occurred and did not specify the severity of trauma, the actual number of times that the abuse 
happened, and did not include items about the symptomology of PTSD or any other trauma- 
related disorder that participants may have met criterion for. Therefore, polyvictimization could 
only be measured by combining sexual and physical trauma data, with the absence of other types 
of trauma, such as emotional and verbal. Also, revictimization was defined by whether a 
participant experienced trauma before and after 18, which leaves gaps in the data such as: at 
what exact age did the trauma occur? Was it a singular incident or did it continue for days, 
weeks, months, years? Or did it occur once and then years later? The age of 18 may be 
considered an arbitrary line between childhood and adulthood trauma, especially for those who 
may have experienced trauma once at 18 and then again the following year. Additionally, while 
participants may not have reported trauma, it is extremely likely that the “no trauma” group did 
in fact experience trauma, which likely impacted the results. In this sense, this study can only 
offer rudimentary information on the nuances of trauma and its impact on treatment. However, 
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the large sample size does give the study ample effect size and power, thus suggesting that its 
results may still be applicable. 
This study was conducted using data from substance use treatment programs that 
participated in the hopes of gaining something from its results, such as government funds and 
acknowledgement of their efficacy. Therefore, the treatment outcomes of this study are not 
necessarily reflective of the average substance use treatment program. In addition, the 
participants of this study were predominantly white, well educated, and were able to afford the 
cost of inpatient care, which has consistently been higher than other levels of treatment over the 
past several years. Also, the average age of the women in this sample was higher than that of 
typical patients in substance use inpatient programs and the majority of them were employed 
prior to their intake. Thus, the treatment outcomes of these individuals may not necessarily be 
representative of women in treatment who belong to racial minority groups, have less education, 
are not gainfully employed, are younger, and are of a lower socio-economic status; individuals 
who share some of these characteristics may be at a higher risk of experiencing trauma and also 
not having the resources to address any mental health concerns that they may be experiencing 
(Gil-Rivas, et al., 2009; Vujanovic, et al., 2016). Additionally, there were some lop-sided groups 
within the Chi-Square and Logistical regression analyses. To address the second hypothesis, 
individuals who reported experiencing both sexual and physical trauma comprised a group much 
smaller than the single trauma group, which decreases the probability of an accurate 
comparison. To address the first hypothesis, other lopsided variables such as age, ethnicity, 
marriage, and education, which may decrease the probability of an accurate comparison. 
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Implications 
 
The results of this study suggest that trauma may impact substance use treatment 
outcomes. In particular, revictimization may be a risk factor. While the very presence of trauma 
may not be a risk factor, research suggests that severity of trauma, PTSD symptomology, and 
other trauma-related issues may be. Additionally, while polyvictimization did not have a 
significant impact on treatment outcomes, it is apparent that type of trauma may be indicative of 
other clinical factors. Also, participants in the study who experienced polyvictimization were 
less likely to relapse than those who had only experienced one type of trauma, which suggests 
that those who have experienced multiple forms of trauma may be more likely to garner 
resiliency and to have addressed trauma prior to substance use treatment. 
There are many conclusions for future research and for substance use treatment 
providers that can be drawn from the results of this study. Future studies should include a more 
diverse population of participants in order to promote understanding of any nuances in 
treatment between groups and to make the sample as representative as possible. Further, a 
greater effort is needed in researching treatment practices of outpatient programs and programs 
that are accessible to a wider group of social classes. Also, identifying trauma and trauma 
related information such as specifics of the trauma, PTSD symptomology, and severity should 
be included in both intake protocols for substance use treatment programs and for research tools 
for future studies. In terms of type of trauma, emotional trauma should be investigated in 
addition to physical and sexual. Regarding substance use treatment methodology, further 
research is needed on the efficacy of trauma informed, women specific substance use treatment 
in order to determine the strength of trauma and trauma related issues’ impact on treatment 
outcomes. 
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In this way, substance use treatment providers can offer the most effective, relevant 
services to women who seek care. 
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APPENDICES 
 
 
Table 1: Trauma-Related Items 
Type of Trauma Age of Trauma Trauma Item 
Physical Childhood “BEFORE you turned 18, were you hit or beaten so hard 
or so often that you had marks or bruises?” 
Sexual Childhood “BEFORE you turned 18, has anyone ever forced you to 
have any kind of sexual intercourse or other genital 
contact with you against your wishes? 
Physical Adulthood “SINCE you were 18, did anyone hit or beat you so hard 
or so often that you had marks?” 
Sexual Adulthood “SINCE you were 18, has anyone ever forced you to 
have any kind of sexual intercourse against your 
wishes?” 
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Table 2 
 
Any Trauma vs. No Trauma Group Differences in Relapse at 6 Months Post-Treatment 
 
 
 
Source Abstained Relapsed Total 
No Trauma 1, 077 (70.3%) 455 (29.7%) 1,532 (49.77%) 
Trauma 1, 025 (66.43) 521 (33.7%) 1,546 (50.23%) 
Total 68.30% 31.70% 3, 078 
 
*Not significant 
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Table 3 
 
Any Trauma vs. No Trauma Group Differences in Re-Entry to Treatment at 6 Months 
 
 
Source No Re-Entry Re-Entry Total 
No Trauma 
1,001 (92.9%) 
77 (7.1%) 1,078 (35.02%) 
Trauma 1,810 (90.5%) 190 (9.5%) 2,000 (64.98%) 
Total 91.33% 
 
8.67% 3, 078 
*Not significant 
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Table 4 
 
Any Trauma vs. No Trauma Group Differences in Relapse at 12 Months Post-Treatment 
 
 
Source Abstained Relapsed Total 
No Trauma 785 (72.8%) 293 (27.2%) 1,078 (35.02%) 
Trauma 1, 343 (67.2%) 657 (32.8%) 2,000 (64.98%) 
Total 69.14% 30.86% 3, 078 
*Not significant 
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Table 5 
 
Any Trauma vs. No Trauma Group Differences in Re-Entry to Treatment at 12 Months 
 
 
Source No Re-Entry Re-Entry Total 
No Trauma 1,439 (93.9%) 93 (6.1%) 1,532 (49.77%) 
Trauma 1,417 (91.66%) 129 (8.34%) 1,546 (50.23%) 
Total 92.78% 7.22% 3, 078 
*Not significant 
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Table 6 
 
Logistical Regression For Relapse at 6 Months 
 
 
Source Odds Ratio Std. Error Z 95% CI 95% CI 
Trauma 1.09 0.1 1.01 0.92 1.30 
Age* 0.99 0.01 -3.07 1.16 1.82 
Ethnicity* 1.45 0.17 3.23 1.16 1.82 
Employment 1.12 0.09 1.36 0.95 1.31 
Marriage Status 1.08 0.12 0.73 0.87 1.342 
Education 1.20 0.17 1.26 0.90 1.59 
Children 0.90 0.08 -1.16 0.76 1.07 
Depression 0.10 0.09 -0.02 0.84 1.19 
Eating Disorders 1.12 0.12 1.03 0.90 1.39 
Polysubstance 0.95 0.08 -0.35 0.79 1.18 
Recent Use* 1.24 0.10 2.62 1.05 1.45 
Injection* 1.55 0.19 3.68 1.23 1.97 
Withdrawal 0.95 0.08 -0.59 0.81 1.12 
Multiple SUDs 1.20 0.12 1.78 0.98 1.46 
Treatment 1.67 0.19 4.60 1.34 2.07 
Completion*      
Constant 0.59 0.18 -1.78 0.33 1.06 
*Indicates significance 
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Table 7 
 
Logistical Regression for Re-Entry to Treatment at 6 Months 
 
 
Source Odds Ratio Std. Error Z 95% CI 95% CI 
Trauma 1.10 0.17 0.60 0.81 1.47 
Age 1.00 0.01 -0.56 0.98 1.01 
Ethnicity* 1.82 0.31 3.53 1.30 2.54 
Employment 1.20 0.16 1.35 0.92 1.56 
Marriage Status 1.15 0.20 0.82 0.82 1.62 
Education 0.87 0.20 -0.61 0.56 1.36 
Children 1.02 0.15 0.12 0.77 1.37 
Depression 1.02 0.15 0.13 0.76 1.37 
Eating Disorders 1.24 0.21 1.29 0.89 1.74 
Polysubstance Use 1.15 0.21 0.75 0.81 1.64 
Recent Use 1.11 0.15 0.78 0.85 1.44 
Injection* 1.63 0.28 2.83 1.16 2.28 
Withdrawal 1.44 0.21 2.49 1.08 1.91 
Multiple SUDs 1.22 0.12 1.25 0.89 1.68 
TXT Completion 2.40 0.37 5.68 1.78 3.25 
Constant* 0.04 0.02 -6.40 0.01 0.11 
*Indicates significance 
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Table 8 
 
Logistical Regression For Relapse at 12 Months 
 
 
Source Odds Ratio Std. Error Z 95% CI 95% CI 
Trauma** 1.20 0.11 1.98 1.01 1.43 
Age* 0.98 0.01 -3.72 0.97 0.99 
Ethnicity 1.05 0.13 0.39 0.83 1.33 
Employment* 1.19 0.10 2.09 1.01 1.40 
Marriage Status* 1.34 0.15 2.62 1.08 1.67 
Education 1.15 0.17 0.96 0.86 1.54 
Children 0.92 0.08 -0.89 0.78 1.10 
Depression* 1.21 0.11 2.07 1.01 1.45 
Eating Disorders 0.84 0.10 -1.53 0.67 1.05 
Polysubstance 1.10 0.12 0.93 0.90 1.35 
Recent Use* 1.47 0.12 4.63 1.25 1.73 
Injection* 1.50 0.18 3.27 1.17 1.90 
Withdrawal 0.92 0.08 -1.00 0.77 1.09 
Multiple SUDs 1.04 0.11 0.36 0.85 1.27 
Treatment 1.12 0.13 0.94 0.89 1.41 
Completion      
Constant 1.03 0.33 0.10 0.55 1.92 
AA Attendance* 0.52 0.06 -5.88 0.42 0.65 
Support Group* 0.77 0.07 -2.93 0.64 0.92 
After Care* 0.78 0.07 -2.83 0.66 0.93 
Re-Entry to 1.63 0.23 3.49 1.24 2.13 
Treatment*     
*Indicates significance  **Approaches significance   
 
Table 9 
 
Logistical Regression for Re-Entry Into Treatment at 12 Months 
 
 
Source Odds Ratio Std. Error Z 95% CI 95% CI 
Trauma 1.02 0.17 0.10 0.73 1.41 
Age* 0.98 0.01 -2.70 0.96 0.99 
Ethnicity* 1.73 0.33 2.93 1.20 2.50 
Employment* 1.37 0.20 2.11 1.02 1.83 
Marriage Status* 0.63 0.13 -2.31 0.43 0.93 
Education 0.89 0.22 -0.44 0.55 1.46 
Children 0.85 0.13 -1.07 0.62 1.15 
Depression 1.11 0.18 0.60 0.80 1.53 
Eating Disorders 0.88 0.17 -0.67 0.59 1.29 
Polysubstance 1.14 0.23 0.66 0.77 1.69 
Recent Use 1.06 0.16 0.39 0.79 1.41 
Injection 1.29 0.24 1.34 0.89 1.87 
Withdrawal* 1.65 0.27 3.14 1.21 2.27 
Multiple SUDs 1.00 0.18 0.00 0.71 1.41 
Treatment 1.65 0.30 2.70 1.15 2.37 
Completion*      
Constant 0.05 0.03 -5.22 0.02 0.15 
AA Attendance 1.15 0.24 0.69 0.77 1.73 
Support Group* 1.42 0.21 2.31 1.05 1.90 
After Care 1.16 0.18 0.95 0.85 1.59 
Relapse* 3.41 0.51 8.21 2.55 4.58 
*Indicates significance 
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Table 10 
 
Single Traumavs. Polyvictimization Group DifferencesinRelapseat6MonthsPost-Treatment 
 
 
Source Abstained Relapsed Total 
Single Trauma 1,198 (67.23%) 584 (32.77%) 1,782 (89.1%) 
Poly Trauma 134 (61.47%) 84 (38.53%) 218 (10.9%) 
Total 66.6% 
 
33.4% 2, 000 
*Not significant 
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Table 11 
 
Single Traumavs. Polyvictimization Group Differencesin Re-Entry to Treatment at 6Months 
 
 
Source No Re-Entry Re-Entry Total 
Single Trauma 1,617 (90.74%) 165 (9.26%) 1,782 (89.1%) 
Poly Trauma 193 (88.53%) 25 (11.47%) 218 (10.9%) 
Total 90.5% 9.5% 2, 000 
*Not significant 
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Table 12 
 
Single Trauma vs. Polyvictimization Group Differences in Relapse at 12 Months Post -Treatment 
 
 
Source Abstained Relapsed Total 
Single Trauma* 1,211 (67.96%) 571 (32.04%) 1,782 (89.1%) 
Poly Trauma 132 (60.55%) 86 (39.45%) 219 (10.9%) 
Total 67.15% 
 
32.85% 2, 000 
*Indicates significant difference 
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Table 13 
 
Single Traumavs. Polyvictimization Group DifferencesinRe-Entry to Treatmentat12Months 
 
 
Source No Re-Entry Re-Entry Total 
Single Trauma 1,645 (92.31%) 137 (7.69%) 1,782 (89.1%) 
Poly Trauma 196 (89.91%) 22 (10.09%) 218 (10.9%) 
Total 92.05% 7.95% 2, 000 
*Not significant 
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Table 14 
 
Before/After 18 vs. Revictimization Group Differences in Relapse at 6 Months Post-Treatment 
 
 
Source Abstained Relapsed Total 
Childhood or Adulthood 683 (68.1%) 320 (31.9%) 1,003 (50.15%) 
Both 649 (65.1%) 348 (34.9%) 997 (49.85%) 
Total 66.6% 33.4% 2, 000 
*Not significant 
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Table 15 
 
Before/After18vs. Revictimization Group DifferencesinRe-Entry to Treatmentat 6 Months 
 
 
Source No Re-Entry Re-Entry Total 
Childhood or Adulthood 918(91.53%) 85(8.47%) 1,003(50.15%)
Both 892(89.47%) 105(10.53%) 997(49.85%)
Total 90.5% 9.5% 2, 000 
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Table 16 
 
Before/After 18 vs. Revictimization Group Differences in Relapse at 12 Months Post-Treatment 
 
 
Source Abstained Relapsed Total 
Childhood or Adulthood 700 (69.79%) 303 (30.21%) 1,003 (50.15%) 
Both* 643 (64.49%) 354 (35.51%) 997 (49.85%) 
Total 67.15% 32.85% 2, 000 
*Indicates significant difference 
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Table 17 
 
Before/After18vs.RevictimizationGroupDifferencesinRe-EntrytoTreatmentat12Months 
 
 
Source No Re-Entry Re-Entry 
 
Total 
Childhood or Adulthood 938 (93.52%) 65 (6.48%) 1,003 (50.15%) 
Both* 903 (90.57%) 94 (9.43%) 997 (49.85%) 
Total 92.05% 7.95% 2, 000 
*Indicates significant difference 
